Interpretation of Roche, Abbott, Beckman, Siemens, Mérieux and other 8 international giants

Release date: 2017-03-14

4. Chemoluminescent multinational giants

The lighting products of multinational giants entered China from the beginning of the 21st century. The four people (RABS) entered China at different rhythms. In 2003, Siemens first entered the Chinese market. Then Beckman, Abbott and other enterprises came to the fore. In 2006, Roche's electrochemiluminescence entered China. Imported brands are rapidly expanding their territory.

Note: The above data is based on the CFDA registration certificate.

In 2003-2013, in just 10 years, the market capacity of chemiluminescence reached 10 billion. With the gradual enrichment and development of detectable projects, the lighting market is still expanding at a rate of doubling in two years. Chemiluminescence maintains the top three growth rates in the global in vitro diagnostic subdivision. From the perspective of geographic region, China is the fastest growing market, with a compound growth rate of 30% in 2011-2016, which can be reported in the annual report of RABS. It is seen that the Chinese region has become the fastest growing market in the region of growth and will continue to be in rapid development in the next three years.

Due to the multi-brand parallel phenomenon of chemiluminescence, all major brands can maintain a high growth rate. During the period of 2011-2016, imported brands maintained a compound growth rate of more than 25%, and will maintain an average growth rate of 20-15% in the next three years.

4.1. Roche's comprehensive strength is strong, and it is the top spot in IVD.

Roche was founded in Switzerland in 1896. In 2015, Roche was 47.5 billion US dollars worldwide, with 78% of medicines and 22% of diagnoses. Roche's excellent products and active sales strategy have made his product lines perform very well, and his comprehensive strength ranks first in the world in in vitro diagnostics.

In the field of immunization, Roche uses electrochemiluminescence as its core product. This product was developed by Baollingman in 1996 and has core patent protection. It is called the fourth generation of chemiluminescence. After Roche acquired the Bollinger Company in 1997, the products were continuously upgraded. Currently, the E170 of 170 T/H and the E411 of 86T/H are the main products. In 2016, Roche Electrochemiluminescence patents officially expired.

At present, there are 105 Roche chemiluminescence projects, covering a wide range of projects, including thyroid function, hormones, allergies, Down syndrome, diabetes, anemia, pre-eclampsia, tumor markers, myocardial markers, concentrated toxemia, transplant drugs. 15 categories of menus, infectious diseases, infectious diseases, bone markers and autoimmunity.

Roche's fist package is a tumor marker, and its menu is constantly improving. The market promotes academic promotion as the main style, and the sample size reaches a certain number of hospital manufacturers to send people to direct sales. Because of Roche's diagnosis products, there are medicines and Pathological products, so the promotion in the clinic can be integrated and promoted. Roche's sales strategy in China is positive. In 2015, Roche diagnosed China's regional sales growth rate of 22%, which is Roche's diagnosis of the world's fastest growing region, with luminescence growth rate of more than 25%.

4.2. Abbott: Adhere to the high-end route, with less success

Abbott was founded in 1888 and started with pharmacy. The Abbott product line is divided into four parts: nutrition, diagnosis, vascular equipment and medicine. In 2015, the global revenue was 20.4 billion US dollars, and the diagnostic product was 4.6 billion US dollars.

Abbott first launched the Axsym series in 1993, followed by its high-end Architect i2000 in 1998. It uses the advanced three-generation luminescence technology, acridine ester direct chemiluminescence, with a maximum speed of 200T/H. After 2008, the Architect i1000 was introduced, gradually replacing the market. On the Axsym, the maximum speed of 100T / H, entered China in 2007.

Abbott products are positioned at the high end, especially in the field of infectious diseases, with strong academic attainments and high loyalty to the end customer base.

Abbott's agent channel sales, a large part of the order system, almost all instruments are placed, but there are strict limits on the amount of reagents.

4.3. Beckman: Balanced development of biochemical immunity, streamlined performance

Beckman was founded in 1935 by Professor Arnold O. Beckman (the inventor of the PH meter). Coulter was founded in 1958 by the Coulter brothers (Wallace and Joseph), and in 1998 the two merged and the new company name was changed to Beckman Coulter. In 2009, Olympus's diagnostic business unit was acquired for US$800 million, and its high-speed biochemical analyzers AU5800 and 2700 became classic models. In 2010, Beckman was acquired by Danaher for $6.8 billion.

Beckman is one of the earliest manufacturers in China. It is mainly divided into Access series and DXI series. The DXI series is a high-speed instrument, up to 400 T/H. It is mainly used in high-end hospitals. The thyroid and hormone projects are fist products.

More than 60 Beckman supporting programs cover 12 major categories including hormones, tumor markers, anemia, cardiac markers, prenatal screening, infectious diseases, and thyroid function.

Beckman biochemical product line has performed well. In recent years, it has seized market share through biochemical immune pipeline. Its DXI series can be connected with DxC biochemical and AU biochemical, which has obvious pulling effect on overall performance.

4.4. Siemens: A wide range of products to meet the needs of customers at all levels

Siemens Medical's sub-diagnosis and imaging are two important departments. After many acquisitions, Siemens Diagnostics has covered all segments of in vitro diagnostics. Its diagnostic products are divided into three major platforms, namely Deling, DPC and Bayer, all acquired in the form of acquisitions.

In May 2006, DPC (Diagnostic Products Corporation) was acquired for US$1.86 billion;

In July 2006, Bayer Medical Group's Diagnostics Division (Bayer Diagnostics) was acquired for US$5.3 billion;

In October 2007, Dade Behring was acquired for $7 billion.

In China, Siemens only sells DPC and Bayer luminaires. Deling products are homogeneously immunized. Domestic Boyang (later acquired by Kemei) has the same product principle as Deling products.

The mainstream models are Bayer's ADVIA CentaurCP/XP series and DPC's IMMULITE series.

There are many models of Siemens instruments, which can cover low-end and mid-end customers. The product testing speed is fast, and the hormone project is a fist product. Siemens has an international brand image and has a good relationship with the government, and the brand is more acceptable. In recent years, similar to Beckman's play, the overall performance has been promoted by the assembly line.

There are two lighting platforms in the China area of ​​Siemens, so the projects carried out are also different. The DPC project is relatively complete, and the number of projects is close to one hundred.

4.5. Diasorin: Small and beautiful company, surprisingly successful

Founded in Italy in 1956, Sorin is now an independent company listed in Italy. Its radioimmunoassay and enzyme immunization enjoy high popularity in Europe and the world.

DiaSorin is currently not well-known in the domestic market, and its market share is still very low, mainly because the domestic market promotion is not large, the direct sales force is not strong, the agents and distributors are relatively narrow, and the number of distributors in China is relatively low. Less, development is relatively slow.

Its mainstream model, the LIAISON series, is known for its special projects and mainly promotes projects such as VD and PCT.

4.6. bioMérieux: rare projects hit the world, individual projects support performance

Mérieux bioMérieux was founded in France in 1963. BioMérieux products are used in two applications: clinical and industrial, in which clinical diagnostic products account for 86% of the total sales, diagnostic products mainly include infectious diseases, microorganisms, cardiovascular diseases And four areas such as oncology.

Mérieux does not belong to the true sense of tubular luminescence, its essence is the enzyme-linked immunoassay method, product positioning is similar to POCT, its core model is VIDAS series mini VIDAS and VIDAS 3, its main project is PCT and heart label.

Mérieux relies on individual projects to support the overall performance, and its development path is worth learning. As long as there are competitive projects with sufficient competitiveness, it can still stand in the lighting market.

4.7. Sysmex: A man of the wind, a roaring enemy

Founded in Japan, Sysmex has a high reputation in the fields of blood analysis, coagulation, and urine. In 2012, its sales amounted to $1,438.7 million, mainly in the blood and urine sediment business. Heathmeacon entered the field of immunization late. In 2014, chemiluminescence was really invested in China, but the growth rate was extremely rapid. In 2016, it is expected to have sales of 300 million yuan, which is extremely fast. Xisen Meikang has a strong online effect on blood, urine and biochemical immunity. It mainly promotes infectious diseases and pre-operative eight items, and the sales strategy is relatively positive.

4.8. Johnson & Johnson OCD (J&J): Segmentation of the field, joint dry chemistry main attack emergency market

Johnson & Johnson was founded in the United States in 1886. In 1974, an Ortho Products Division was independently a separate subsidiary. In 1994, it acquired the clinical diagnostic department of Eastman Kodak Co., and in 1997 merged Kodak Diagnostics and Ortho Products. For Ortho Clinical Diagnostics, OCD. In 2014, the OCD department was spun off and acquired by Carlyle Medical.

In 1997, the first fully automatic illuminating immunoassay instrument Vitros ECi was launched, with a speed of 100T/H. The subsequent evolution and evolution also introduced the Vitros 5600 biochemical immune integrated machine. OCD's luminescence is mainly tied to dry biochemistry, and it focuses on the emergency market.

Source: POCT Information

Injection Molding Agent Processing Business

Shoulder Protection Veterinary Gloves,Colorful Disposable Veterinary Gloves,Inclined Cutting Gloves,Sleeve Shoulder Tight Injection Molding Agent Product,Pe Shoulder Protection Product,Veterinary Pe Glove,Disposable Veteri

Jinan Mucho Commercial Inc. , https://www.muchovet.com